Investor Notice: Robbins LLP Informs Investors of the Agilon Health, Inc. Securities Class Action

Core Viewpoint - Robbins LLP has initiated a class action lawsuit on behalf of investors who acquired Agilon Health, Inc. (NYSE: AGL) securities between February 26, 2025, and August 4, 2025, alleging that the company misled investors regarding its business prospects [1] Allegations - The complaint asserts that Agilon Health, Inc. failed to disclose that it issued guidance for 2025 that was unrealistic, given the material industry challenges they were aware of, and that they materially overstated the financial benefits from strategic actions taken to mitigate risks [2] Company Developments - On August 4, 2025, Agilon announced the resignation of Steven Sell as President, CEO, and Director, stating that his departure was a termination without 'cause' according to his employment agreement. The same day, the company released disappointing financial results, leading to a stock price drop of over 50%, closing at $0.8801 on August 5, 2025 [3] Class Action Participation - Shareholders may be eligible to participate in the class action against Agilon Health, Inc. Those interested in serving as lead plaintiffs should contact Robbins LLP. Participation is not required to be eligible for recovery, and shareholders can choose to remain absent class members [4]